Clinical Diagnosis and Management of Alzheimer's Disease, Third Edition

The third edition of this successful textbook has been completely updated throughout and includes new chapters on electrophysiological tests, biological markers, global staging measures, and management of neuropsychiatric symptoms. There has been steady progress in our understanding of the natural history, prognostic factors and treatments for AlzheimerвЂTMs disease since the previous edition of this textbook was published in 1999. The chapters deal with the full spectrum of populations at risk, persons in prodromal stages, and patients from mild to severe and even terminal stages. The contributors are opinion leaders from North America and Europe, which gives the book an internationally balanced outlook. This new edition will be essential reading for a wide range of clinical neuroscientists who manage patients with this challenging disease. Definitions and diagnostic criteria Pathophysiology: a neurochemical perspective Pathophysiology: an epidemiological perspective Typical clinical features Differentiation from non-Alzheimer dementia Neuropsychological assessment Structural brain imaging Functional brain imaging Electrophysiological tests Biological markers Natural decline and prognostic factors Global assessment measures Depressive syndrome in Alzheimer's disease Cognition Functional autonomy Behaviour Mild cognitive impairment and very early stage Alzheimer's disease Mild to moderate stages Care of patients in the severe stage of dementia Terminal stage Co-existent medical problems and concomitant diseases Management of neuropsychiatric symptoms Caregiver support: support of families Community -based formal support services Ethical issues Competency Genetic counselling Health-related quality of life measurement techniques in the management of dementia Future diagnosis and management of Alzheimer's disease. "The third edition of this successful textbook Clinical Diagnosis and Management of Alzheimer's Disease has been completely updated throughout and includes new chapters on electrophysiological tests, biological markers, global staging measures and management of neuropsychiatric symptoms. There has been steady progress in our understanding of the natural history, prognostic factors and treatments for Alzheimer's disease since the previous edition of this textbook was published in 1999. The chapters deal with the full spectrum of populations at risk, persons in prodromal stages, and patients from mild to severe and even terminal stages. The contributors are opinion leaders from North America and Europe, which gives the book an internationally balanced outlook. This new edition will be essential reading for a wide range of clinical neuroscientists who manage patients with this challenging disease."--[Résumé de l'éditeur] Includes information on electrophysiological tests, biological markers, global staging measures, and management of neuropsychiatric symptoms. This book looks at our understanding of the natural history, prognostic factors and treatments for Alzheimer's disease. It deals with the populations at risk, persons in prodromal stages, and more Alzheimer's disease (AD) is a progressive neurodegenerative disorder with characteristic clinical and pathological features.